These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2786777)

  • 1. The therapeutic efficacy of an anti-IL-2 receptor monoclonal antibody correlates with an increase in serum soluble IL-2 receptor levels.
    Volk HD; Josimovic-Alasevic O; Gross M; Diamantstein T
    Clin Exp Immunol; 1989 Apr; 76(1):121-5. PubMed ID: 2786777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blocking of interleukin 2 (IL 2) binding to the IL 2 receptor is not required for the in vivo action of anti-IL 2 receptor monoclonal antibody (mAb). I. The production, characterization and in vivo properties of a new mouse anti-rat IL 2 receptor mAb that reacts with an epitope different to the one that binds to IL 2 and the mAb ART-18.
    Mouzaki A; Volk HD; Osawa H; Diamantstein T
    Eur J Immunol; 1987 Mar; 17(3):335-41. PubMed ID: 3106058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of in-vivo administration of a monoclonal antibody specific for the interleukin-2 receptor on the acute graft-versus-host reaction in mice.
    Volk HD; Brocke S; Osawa H; Diamantstein T
    Clin Exp Immunol; 1986 Oct; 66(1):126-31. PubMed ID: 3100116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-interleukin 2 receptor antibody suppresses delayed-type hypersensitivity to foreign and syngeneic antigens.
    Kelley VE; Naor D; Tarcic N; Gaulton GN; Strom TB
    J Immunol; 1986 Oct; 137(7):2122-4. PubMed ID: 3093566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
    Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
    Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effects of anti-interleukin 2 receptor and anti-L3T4 antibodies on delayed type hypersensitivity: the role of complement and epitope.
    Kelley VE; Gaulton GN; Strom TB
    J Immunol; 1987 May; 138(9):2771-5. PubMed ID: 3106488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of the local graft-vs.-host reaction in rats by treatment with a monoclonal antibody specific for the interleukin 2 receptor.
    Volk HD; Brocke S; Osawa H; Diamantstein T
    Eur J Immunol; 1986 Oct; 16(10):1309-12. PubMed ID: 2945730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of allograft rejection and organ-specific autoimmune disease by anti-interleukin-2 receptor (IL-2R)-targeted immunotherapy. The action of anti-IL-2R monoclonal antibodies and synergistic effect of cyclosporin A.
    Diamantstein T; Mouzaki A; Osawa H; Volk HD; Hahn HJ; Kirkman RL; Strom TB; Tilney NL; Kupiec-Weglinski JW
    Dev Biol Stand; 1988; 69():177-84. PubMed ID: 3066671
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-IL-2 receptor monoclonal antibody AMT-13 increases soluble IL-2 receptor levels in vivo.
    Burkhardt K; Mandel TE; Diamantstein T; Loughnan MS
    Immunology; 1989 Feb; 66(2):183-9. PubMed ID: 2647626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin 2 receptors are released by cells in vitro and in vivo. I. Detection of soluble IL 2 receptors in cell culture supernatants and in the serum of mice by an immunoradiometric assay.
    Osawa H; Josimovic-Alasevic O; Diamantstein T
    Eur J Immunol; 1986 Apr; 16(4):467-9. PubMed ID: 2422044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A soluble interleukin 2 receptor produced by a normal alloreactive human T cell clone binds interleukin 2 with low affinity.
    Jacques Y; Le Mauff B; Boeffard F; Godard A; Soulillou JP
    J Immunol; 1987 Oct; 139(7):2308-16. PubMed ID: 2821110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Constitutive secretion of soluble interleukin-2 receptor by human T cell lymphoma xenografted into SCID mice. Correlation of tumor volume with concentration of tumor-derived soluble interleukin-2 receptor in body fluids of the host mice.
    Wasik MA; Sioutos N; Tuttle M; Butmarc JR; Kaplan WD; Kadin ME
    Am J Pathol; 1994 May; 144(5):1089-97. PubMed ID: 8178932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioimmunotherapy of nude mice bearing a human interleukin 2 receptor alpha-expressing lymphoma utilizing the alpha-emitting radionuclide-conjugated monoclonal antibody 212Bi-anti-Tac.
    Hartmann F; Horak EM; Garmestani K; Wu C; Brechbiel MW; Kozak RW; Tso J; Kosteiny SA; Gansow OA; Nelson DL
    Cancer Res; 1994 Aug; 54(16):4362-70. PubMed ID: 8044783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated titers of cell-free interleukin 2 receptor in serum of lupus mice.
    Balderas RS; Josimovic-Alasevic O; Diamantstein T; Dixon FJ; Theofilopoulos AN
    J Immunol; 1987 Sep; 139(5):1496-500. PubMed ID: 3114368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients.
    Shaiegan M; Iravani M; Babaee GR; Ghavamzadeh A
    Transpl Immunol; 2006 Jan; 15(3):223-7. PubMed ID: 16431290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific immunosuppressive therapy by monoclonal anti-IL 2 receptor antibody and its synergistic action with cyclosporin.
    Diamantstein T; Volk HD; Tilney NL; Kupiec-Weglinski J
    Immunobiology; 1986 Sep; 172(3-5):391-9. PubMed ID: 3100433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of IL 2R+ T cells and macrophages within rejecting rat cardiac allografts, and comparison of the effects of treatment with anti-IL 2R monoclonal antibody or cyclosporin.
    Hancock WW; Lord RH; Colby AJ; Diamantstein T; Rickles FR; Dijkstra C; Hogg N; Tilney NL
    J Immunol; 1987 Jan; 138(1):164-70. PubMed ID: 3097143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The in vitro effect on T cell function of soluble IL-2Ralpha from advanced ovarian cancer ascites.
    Elg SA; Hill RB; Heldman L; Ramakrishnan S
    Gynecol Oncol; 1997 Jul; 66(1):133-7. PubMed ID: 9234933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The acquisition of cytokine responsiveness by murine B cells: a role for antigen and IL-5 in the induction of IL-2 receptors.
    Poudrier J; Owens T
    Immunology; 1994 Mar; 81(3):373-80. PubMed ID: 8206511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved biodistribution of 125I-labeled anti-Tac disulfide-stabilized Fv fragment by blocking its binding to the alpha subunit of the interleukin 2 receptor in the circulation with preinjected humanized anti-Tac IgG.
    Kobayashi H; Yoo TM; Drumm D; Kim MK; Sun BF; Le N; Webber KO; Pastan I; Waldmann TA; Paik CH; Carrasquillo JA
    Cancer Res; 1997 May; 57(10):1955-61. PubMed ID: 9157991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.